Literature DB >> 18579178

Requirements of the membrane proximal tyrosine and dileucine-based sorting signals for efficient transport of the subtype C Vpu protein to the plasma membrane and in virus release.

Autumn Ruiz1, M Sarah Hill, Kimberly Schmitt, John Guatelli, Edward B Stephens.   

Abstract

Previously, we showed that the Vpu protein from HIV-1 subtype C is more efficiently transported to the cell surface than the well studied subtype B Vpu (Pacyniak et al., 2005) and that a SHIV expressing the subtype C Vpu exhibited a decreased rate of CD4+ T cell loss following inoculation in macaques (Hill et al., 2008). In this study, we examined the role of overlapping tyrosine-based (YXXPhi) and dileucine-based ([D/E]XXXL[L/I]) motifs in the membrane proximal region of the subtype C Vpu (EYRKLL) in Vpu intracellular transport, CD4 surface expression and virus release from the cell surface. We constructed three site-directed mutants of the subtype C vpu and fused these genes to the gene for enhanced green fluorescent protein (EGFP). The first mutation made altered the tyrosine (EARKLL; VpuSCEGFPY35A), the second altered the dileucine motif (EYRKLG; VpuSCEGFPL39G), and the third contained both amino acid substitutions (EARKLG; VpuSCEGFPYL35,39AG) in this region of the Vpu protein. The VpuSCEGFPY35A protein was transported to the cell surface similar to the unmodified VpuSCEGFP1 while VpuSCEGFPL39G was expressed at the cell surface at significantly reduced levels. The VpuSCEGFPYL35,39AG was found to have an intermediate level of cell surface expression. All three mutant Vpu proteins were analyzed for the ability to prevent cell surface expression of CD4. We found that both single mutants did not significantly effect CD4 surface expression while the double mutant (VpuSCEGFPYL35,39AG) was significantly less efficient at preventing cell surface CD4 expression. Chimeric simian human immunodeficiency viruses were constructed with these mutations in vpu (SHIVSCVpuY35A, SHIVSCVpuL39G and SHIVSCVpuYL35,39AG). Our results indicate that SHIVSCVpuL39G replicated much more efficiently and was much more cytopathic than SHIVSCVpu. In contrast, SHIVSCVpuY35A and SHIVSCVpuYL35,39AG replicated less efficiently when compared to the parental SHIVSCVpu. Taken together, these results show for the first time that the membrane proximal tyrosine-based sorting motif in the cytoplasmic domain of Vpu is essential for efficient virus release. These results also indicate that the dileucine-based sorting motif affects the intracellular trafficking of subtype C Vpu proteins, virus replication, and release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579178      PMCID: PMC4104992          DOI: 10.1016/j.virol.2008.05.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  59 in total

1.  The structure of the HIV-1 Vpu ion channel: modelling and simulation studies.

Authors:  F S Cordes; A Kukol; L R Forrest; I T Arkin; M S Sansom; W B Fischer
Journal:  Biochim Biophys Acta       Date:  2001-06-06

2.  A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells.

Authors:  K C Miranda; T Khromykh; P Christy; T L Le; C J Gottardi; A S Yap; J L Stow; R D Teasdale
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

3.  Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates.

Authors:  C McCormick-Davis; S B Dalton; D K Singh; E B Stephens
Journal:  AIDS Res Hum Retroviruses       Date:  2000-07-20       Impact factor: 2.205

4.  Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.

Authors:  Edward B Stephens; Coleen McCormick; Erik Pacyniak; Darcy Griffin; David M Pinson; Francis Sun; Warren Nothnick; Scott W Wong; Robert Gunderson; Nancy E J Berman; Dinesh K Singh
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

5.  A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.

Authors:  C McCormick-Davis; S B Dalton; D R Hout; D K Singh; N E Berman; C Yong; D M Pinson; L Foresman; E B Stephens
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

6.  Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein.

Authors:  F Maldarelli; M Y Chen; R L Willey; K Strebel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Identification of a protein encoded by the vpu gene of HIV-1.

Authors:  E A Cohen; E F Terwilliger; J G Sodroski; W A Haseltine
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

8.  Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu.

Authors:  Gary D Ewart; Kerry Mills; Graeme B Cox; Peter W Gage
Journal:  Eur Biophys J       Date:  2002-03       Impact factor: 1.733

9.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

Review 10.  Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.

Authors:  David R Hout; Ellyn R Mulcahy; Erik Pacyniak; Lisa M Gomez; Melissa L Gomez; Edward B Stephens
Journal:  Curr HIV Res       Date:  2004-07       Impact factor: 1.581

View more
  22 in total

1.  Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens.

Authors:  David Lau; Wilson Kwan; John Guatelli
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors.

Authors:  Charlotte A Stoneham; Rajendra Singh; Xiaofei Jia; Yong Xiong; John Guatelli
Journal:  Traffic       Date:  2017-06-27       Impact factor: 6.215

3.  Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release.

Authors:  Autumn Ruiz; M Sarah Hill; Kimberly Schmitt; Edward B Stephens
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

4.  The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.

Authors:  Shilpi Sharma; Moein Jafari; Amandip Bangar; Karen William; John Guatelli; Mary K Lewinski
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

5.  A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.

Authors:  Janet L Douglas; Ying Bai; Jean K Gustin; Ashlee V Moses
Journal:  Virology       Date:  2013-04-10       Impact factor: 3.616

Review 6.  The great escape: viral strategies to counter BST-2/tetherin.

Authors:  Janet L Douglas; Jean K Gustin; Kasinath Viswanathan; Mandana Mansouri; Ashlee V Moses; Klaus Früh
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

7.  Simian-Human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaques.

Authors:  Autumn Ruiz; Kimberly Schmitt; Nathan Culley; Edward B Stephens
Journal:  Virology       Date:  2012-12-05       Impact factor: 3.616

8.  Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.

Authors:  Yingying Li; Jean-Bosco Ndjango; Gerald H Learn; Miguel A Ramirez; Brandon F Keele; Frederic Bibollet-Ruche; Weimin Liu; Juliet L Easlick; Julie M Decker; Rebecca S Rudicell; Bila-Isia Inogwabini; Steve Ahuka-Mundeke; Fabian H Leendertz; Vernon Reynolds; Martin N Muller; Rebecca L Chancellor; Aaron S Rundus; Nicole Simmons; Michael Worobey; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

9.  Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.

Authors:  Chia-Yen Chen; Masashi Shingai; Sarah Welbourn; Malcolm A Martin; Pedro Borrego; Nuno Taveira; Klaus Strebel
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

10.  Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network.

Authors:  Mathieu Dubé; Bibhuti Bhusan Roy; Pierre Guiot-Guillain; Johanne Mercier; Julie Binette; Grace Leung; Eric A Cohen
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.